Now and later? The sticky question of lymph node management in patients receiving preoperative chemotherapy

Annals of Surgical Oncology

Volumn 12, Issue 9, 2005, Pages 683-685

  Hunt, Kelly K ^a   Buchholz, Thomas A ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; TAXANE DERIVATIVE;

BREAST TUMOR; CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CONSERVATIVE TREATMENT; EDITORIAL; HUMAN; LYMPH NODE; METASTASIS; MORBIDITY; PARTIAL MASTECTOMY; PREOPERATIVE CARE; PROGNOSIS; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; NEOADJUVANT THERAPY; RADIOTHERAPY; SENTINEL LYMPH NODE BIOPSY;

EID: 23944463925     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2005.03.906     Document Type: Editorial

References (8)

1. Xing Y, Cormier JN, Kuerer HM, Hunt KK. Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management. Asian J Surg 2004;27:262-7.
2. Kawase K, Hunt KK, Kuerer H, et al. Sentinel lymph node biopsy accurately reflects nodal status following preoperative chemotherapy for breast cancer (abstract 82). Ann Surg Oncol 2004;11:S75.
3. Mamounas EP. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 2003;83:931-42.
4. Khan SA, Wolfman JA, Segal L, et al. Ductal lavage findings in women with mammographic microcalcifications undergoing biopsy. Ann Surg Oncol (in press).
5. Buzdar AU, Singletary SE, Valero V, et al. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res 2002;8:1073-9.
6. Kuerer HM, Hunt KK. The rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer patients receiving neoadjuvant chemotherapy. Semin Breast Dis 2002;5:80-7.
7. Buchholz TA, Hunt KK, Whitman GJ, Sahin AA, Hortobagyi GN. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer 2003;98:1150-60.
8. Shen J, Mirza NQ, Gilcrease M, et al. Feasibility and accuracy of sentinel lymph node biopsy following neoadjuvant chemotherapy in breast cancer patients with cytologically proven axillary metastases (abstract 2013). Breast Cancer Res Treat 2004;88 (Suppl 1):S81.